Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Early Protein antibody

Reactivity: Human Papillomavirus 16 (HPV-16) ELISA, WB Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN1993425
  • Target
    Early Protein
    Reactivity
    • 3
    • 2
    Human Papillomavirus 16 (HPV-16)
    Host
    • 5
    Rabbit
    Clonality
    • 5
    Polyclonal
    Conjugate
    • 2
    • 1
    • 1
    • 1
    Un-conjugated
    Application
    • 3
    • 3
    • 2
    ELISA, Western Blotting (WB)
    Purification
    Caprylic Acid Ammonium Sulfate Precipitation
    Immunogen
    Recombinant human papillomavirus type 16 Protein E6 protein
    Isotype
    IgG
  • Application Notes
    Optimal working concentration should be determinde by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    0.03 % Proclin 300, 53 % Glycerol, 0.01 M PBS, pH 7.4
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClinTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Handling Advice
    Avoid repeated freeze.
    Storage
    -20 °C/-80 °C
    Storage Comment
    Upon delivery aliquot and store at -20 °C or -80 °C.
  • Target
    Early Protein
    Alternative Name
    Protein E6
    Synonyms
    early protein 6 antibody, E6 antibody
    Target Type
    Viral Protein
    Background
    Plays a major role in the induction and maintenance of cellular transformation. Acts mainly as an oncoprotein by stimulating the destruction of many host cell key regulatory proteins. E6 associates with host E6-AP ubiquitin-protein ligase, and inactivates tumor suppressors TP53 and TP73 by targeting them to the 26S proteasome for degradation. In turn, DNA damage and chromosomal instabilities increase and lead to cell proliferation and cancer development. The complex E6/E6P targets several other substrates to degradation via the proteasome including host NFX1-91, a repressor of human telomerase reverse transcriptase (hTERT). The resulting increased expression of hTERT prevents the shortening of telomere length leading to cell immortalization. Other cellular targets including Bak, Fas-associated death domain-containing protein (FADD) and procaspase 8, are degraded by E6/E6AP causing inhibition of apoptosis. E6 also inhibits immune response by interacting with host IRF3 and TYK2. These interactions prevent IRF3 transcriptional activities and inhibit TYK2-mediated JAK-STAT activation by interferon alpha resulting in inhibition of the interferon signaling pathway.
    Synonyms: E6
    UniProt
    P03126
You are here:
Support